A Framework for Understanding Systemic Vulnerability and Targeted Care in Sepsis Among Patients with Multimorbidity - Scorecard - MDSpire

A Framework for Understanding Systemic Vulnerability and Targeted Care in Sepsis Among Patients with Multimorbidity

  • By

  • Jhan S. Saavedra-Torres

  • Humberto Alejandro Nati-Castillo

  • Alice Gaibor-Pazmiño

  • Wilder Fernando Ortiz Erazo

  • María Alejandra Martínez Castaño

  • Cristhian Camilo Nieto Brandon

  • Diana Catalina Parra Ramos

  • Juan Villamil

  • Leonardo Sánchez S.

  • Andrés López-Cortés

  • Juan S. Izquierdo-Condoy

  • April 28, 2026

  • 0 min

Share

Clinical Scorecard: A Framework for Understanding Systemic Vulnerability and Targeted Care in Sepsis Among Patients with Multimorbidity

At a Glance

CategoryDetail
ConditionSepsis
Key MechanismsDysregulated inflammatory response, low-grade inflammation, impaired immunity, endothelial injury, immunothrombosis, dysbiosis, neuroendocrine maladaptation.
Target PopulationPatients with multimorbidity including type 2 diabetes, obesity, heart failure, COPD, chronic kidney disease, cancer/HIV, and severe mental illness.
Care SettingHospital settings, particularly intensive care units (ICUs) and neonatal units.

Key Highlights

  • Sepsis is a leading cause of morbidity and mortality, exacerbated by multimorbidity.
  • Chronic diseases significantly increase the risk and severity of sepsis.
  • Nosocomial sepsis has high incidence and mortality rates, particularly in critically ill patients.
  • Personalized care strategies are essential for managing sepsis in patients with comorbidities.
  • Long-term follow-up is crucial for sepsis survivors due to persistent neurological and psychosocial sequelae.

Guideline-Based Recommendations

Diagnosis

  • Identify sepsis through clinical signs of infection and systemic inflammatory response.

Management

  • Implement mechanism- and phenotype-aligned care, including titrated fluids and timely antimicrobial de-escalation.

Monitoring & Follow-up

  • Monitor immune and organ function, utilizing markers like monocyte HLA-DR and NGAL/KIM-1.

Risks

  • Assess risks associated with chronic comorbidities and nosocomial infections.

Patient & Prescribing Data

Patients with multimorbidity, particularly those with chronic conditions.

Focus on rigorous control of chronic comorbidities and preventive strategies against infections.

Clinical Best Practices

  • Develop stronger prevention bundles for hospital-acquired sepsis.
  • Conduct endotyping and mechanism-matched therapy trials.
  • Implement post-sepsis follow-up to address long-term outcomes.

References

Original Source(s)

Related Content